CDSCO UID MFG/MD/2020/000017_f7e5e5cdcfe40dff301cd7c96989696d_63a4f3784bdbcf46390e7d3df350dd3bFEBRILE S. TYPHI O ANTIGEN(SEROCON FEBRILE S. TYPHI O ANTIGEN )
- UID
- MFG/MD/2020/000017_f7e5e5cdcfe40dff301cd7c96989696d_63a4f3784bdbcf46390e7d3df350dd3b
- Device class
- Class B
- Brand name
- SEROCON CYSTATIN C CONTROL SET
- License holder
- Beacon Diagnostics Pvt. Ltd.
- Approving authority
- Gujarat
- Product information
- For detection of specific antibodies present in response to the stimulation by specific antigen of salmonella (SEROCON CYSTATIN C CONTROL SET)
FEBRILE S. TYPHI O ANTIGEN(SEROCON FEBRILE S. TYPHI O ANTIGEN ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2020/000017_f7e5e5cdcfe40dff301cd7c96989696d_63a4f3784bdbcf46390e7d3df350dd3b. This device is marketed under the brand name SEROCON CYSTATIN C CONTROL SET. The license holder is Beacon Diagnostics Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is Gujarat.
This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.